SIMVASTATIN (MK 733) IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A 2-YEAR TRIAL

被引：0
|
作者：
LECLERCQ, V
HARVENGT, C
机构：
[1] CATHOLIC UNIV LOUVAIN, PHARMACOTHERAPY LAB, 53 AVE E MOUNIER, B-1200 BRUSSELS, BELGIUM
[2] ST LUC UNIV CLIN, DEPT INTERNAL MED, B-1200 BRUSSELS, BELGIUM
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1989年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：76 / 81
页数：6
相关论文
共 50 条
  • [31] THE INFLUENCE OF SIMVASTATIN ON ADRENAL CORTICOSTEROID PRODUCTION AND URINARY MEVALONATE DURING ADRENOCORTICOTROPIN STIMULATION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    PRIHODA, JS
    PAPPU, AS
    SMITH, FE
    ILLINGWORTH, DR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (03): : 567 - 574
  • [32] Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin
    Alonso, R
    Mata, P
    De Andres, R
    Villacastin, BP
    Martínez-González, J
    Badimon, L
    ATHEROSCLEROSIS, 2001, 157 (02) : 423 - 429
  • [33] Sitostanol ester margarine without and with simvastatin in dietary treatment or families heterozygous of familial hypercholesterolemia North Karelia deletion
    Vuorio, AF
    Gylling, H
    Turtola, H
    Kontula, K
    Miettinen, TA
    CIRCULATION, 1998, 98 (17) : 533 - 534
  • [34] High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia
    Twickler, TB
    Dallinga-Thie, GM
    de Valk, HW
    Schreuder, PCNJ
    Jansen, H
    Cabezas, MC
    Erkelens, DW
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) : 2422 - 2427
  • [35] Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia
    Geiss, HC
    Schwandt, P
    Parhofer, KG
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2002, 110 (04) : 182 - 187
  • [36] One-year efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia
    Hedman, M
    Matikainen, T
    Föhr, A
    Lappi, M
    Piippo, S
    Nuutinen, M
    Antikainen, M
    EUROPEAN HEART JOURNAL, 2004, 25 : 37 - 38
  • [37] SITOSTEROLEMIA AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN A 3 YEAR OLD GIRL - CASE-REPORT
    NYE, ER
    SUTHERLAND, WHF
    MORTIMER, JG
    STRINGER, HCW
    NEW ZEALAND MEDICAL JOURNAL, 1988, 101 (848) : 418 - 419
  • [38] Familial Hypercholesterolemia within Cardiology Practice - Single-Center Experience during 2-Year Period
    Begic, Edin
    Djozic, Ada
    Karavelic, Emina
    Zatric, Nadira
    Sinancevic, Adela
    Dzubur, Alen
    Durak-Nalbantic, Azra
    Begic, Alden
    Begic, Nedim
    Sahbaz, Amina
    Hasanagic, Esma
    Gogic, Ena
    Naser, Nabil
    Zukic, Fuad
    Medjedovic, Edin
    Iglica, Amer
    Halilcevic, Mirela
    Begic, Zijo
    RESEARCH IN CARDIOVASCULAR MEDICINE, 2022, 11 (03) : 81 - 85
  • [39] Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia - A randomized controlled trial
    Stein, EA
    Illingworth, DR
    Kwiterovich, PO
    Liacouras, CA
    Siimes, MA
    Jacobson, MS
    Brewster, TG
    Hopkins, P
    Davidson, M
    Graham, K
    Arensman, F
    Knopp, RH
    DuJovne, C
    Williams, CL
    Isaacsohn, JL
    Jacobsen, CA
    Laskarzewski, PM
    Ames, S
    Gormley, GJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02): : 137 - 144
  • [40] Two-year efficacy and safety of Simvastatin 80 mg in familial hypercholesterolemia (The examination of probands and relatives in statin studies with familial hypercholesterolemia [ExPRESS FH])
    Nolting, PRWD
    Buirma, RJA
    Hutten, BA
    Kastelein, JJP
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (02): : 181 - +
12345